Is Driver a story of fast fail or a cautionary tale against pursuing DTC model?
Driver reportedly raised around $100 million and had top medical minds on its scientific advisory board, but the $3,000 price tag for its services that its cancer patients would have to pay appears to have been a flawed model to begin with.